News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Galante Joseph C
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2023 |
4
| Galante Joseph C (Director) has filed a Form 4 on PINNACLE FINANCIAL PARTNERS INC|
Txns:
| Paid exercise price by delivering 174 shares
@ $74.09, valued at
$12.9k
Granted 1,084 shares
@ $0 |
|
| 01/23/2023 |
4
| Galante Joseph C (Director) has filed a Form 4 on PINNACLE FINANCIAL PARTNERS INC|
Txns:
| Bought 1,000 shares
@ $72.26, valued at
$72.3k
|
|
| 11/18/2022 |
4
| Galante Joseph C (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 65 shares
@ $2.57, valued at
$167.1
Bought 65 shares
@ $2.52, valued at
$163.8
Bought 65 shares
@ $2.51, valued at
$163.2
Bought 65 shares
@ $2.61, valued at
$169.7
Bought 65 shares
@ $2.54, valued at
$165.1
Bought 65 shares
@ $2.61, valued at
$169.7
Bought 65 shares
@ $2.58, valued at
$167.7
Bought 65 shares
@ $2.65, valued at
$172.3
Bought 65 shares
@ $2.66, valued at
$172.9
Bought 65 shares
@ $2.53, valued at
$164.5
Bought 65 shares
@ $2.48, valued at
$161.2 |
|
| 09/30/2022 |
4
| Galante Joseph C (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 65 shares
@ $2.35, valued at
$152.8
Bought 65 shares
@ $2.31, valued at
$150.2
Bought 65 shares
@ $2.23, valued at
$145
Bought 65 shares
@ $2.35, valued at
$152.8
Bought 65 shares
@ $2.51, valued at
$163.2
Bought 65 shares
@ $2.59, valued at
$168.4
Bought 65 shares
@ $2.59, valued at
$168.4
Bought 65 shares
@ $2.62, valued at
$170.3
Bought 65 shares
@ $2.55, valued at
$165.8
Bought 70 shares
@ $2.44, valued at
$170.8
Bought 70 shares
@ $2.38, valued at
$166.6 |
|
| 08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/05/2021 |
4
| Galante Joseph C (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 142 shares
@ $2.69, valued at
$382
Bought 142 shares
@ $2.87, valued at
$407.5
Bought 142 shares
@ $2.82, valued at
$400.4
Bought 142 shares
@ $2.76, valued at
$391.9
Bought 142 shares
@ $2.76, valued at
$391.9
Bought 142 shares
@ $2.84, valued at
$403.3
Bought 142 shares
@ $2.73, valued at
$387.7
Bought 142 shares
@ $2.71, valued at
$384.8
Bought 142 shares
@ $2.71, valued at
$384.8
Bought 142 shares
@ $2.81, valued at
$399
Bought 142 shares
@ $2.76, valued at
$391.9 |
|
| 10/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/28/2020 |
4
| Galante Joseph C (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 225 shares
@ $3.37, valued at
$758.3
Bought 375 shares
@ $3.41, valued at
$1.3k
Bought 375 shares
@ $3.37, valued at
$1.3k
Bought 300 shares
@ $3.34, valued at
$1k
Bought 375 shares
@ $3.31, valued at
$1.2k
Bought 375 shares
@ $3.29, valued at
$1.2k
Bought 375 shares
@ $3.33, valued at
$1.2k
Bought 375 shares
@ $3.26, valued at
$1.2k
Bought 375 shares
@ $3.42, valued at
$1.3k
Bought 375 shares
@ $3.44, valued at
$1.3k
Bought 375 shares
@ $3.35, valued at
$1.3k
|
|
| 06/12/2020 |
4
| Galante Joseph C (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 75 shares
@ $4.03, valued at
$302.3
Bought 150 shares
@ $4.05, valued at
$607.5
Bought 150 shares
@ $4.04, valued at
$606
Bought 150 shares
@ $4.03, valued at
$604.5
Bought 150 shares
@ $4.03, valued at
$604.5
Bought 150 shares
@ $4.02, valued at
$603
Bought 150 shares
@ $4.01, valued at
$601.5
Bought 150 shares
@ $4.01, valued at
$601.5
Bought 150 shares
@ $3.99, valued at
$598.5
Bought 150 shares
@ $3.97, valued at
$595.5
Bought 150 shares
@ $4.02, valued at
$603 |
|
| 06/05/2020 |
4
| Galante Joseph C (Director) has filed a Form 4 on PINNACLE FINANCIAL PARTNERS INC|
Txns:
| Bought 4,000 shares
@ $25, valued at
$100k
|
|
| 04/17/2020 |
4
| Galante Joseph C (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Granted 1,000 shares
@ $3.56, valued at
$3.6k
|
|
| 03/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/20/2019 |
4
| Galante Joseph C (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 60 shares
@ $5.87, valued at
$352.2
Bought 60 shares
@ $5.86, valued at
$351.6
Bought 60 shares
@ $5.87, valued at
$352.2
Bought 60 shares
@ $5.83, valued at
$349.8
Bought 60 shares
@ $5.94, valued at
$356.4
Bought 120 shares
@ $6.15, valued at
$738
Bought 60 shares
@ $6.17, valued at
$370.2
Bought 60 shares
@ $6.07, valued at
$364.2
Bought 120 shares
@ $6.02, valued at
$722.4
Bought 60 shares
@ $5.91, valued at
$354.6
Bought 60 shares
@ $5.78, valued at
$346.8 |
|
| 07/26/2019 |
4
| Galante Joseph C (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 60 shares
@ $6.42, valued at
$385.2
Bought 60 shares
@ $6.37, valued at
$382.2
Bought 60 shares
@ $6.33, valued at
$379.8
Bought 60 shares
@ $6.36, valued at
$381.6
Bought 60 shares
@ $6.35, valued at
$381
Bought 60 shares
@ $6.33, valued at
$379.8
Bought 60 shares
@ $6.34, valued at
$380.4
Bought 60 shares
@ $6.54, valued at
$392.4
Bought 60 shares
@ $6.56, valued at
$393.6
Bought 60 shares
@ $6.54, valued at
$392.4
Bought 60 shares
@ $6.48, valued at
$388.8 |
|
| 06/14/2019 |
4
| Galante Joseph C (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 99 shares
@ $6.32, valued at
$625.7
Bought 81 shares
@ $6.21, valued at
$503
Bought 32 shares
@ $6.04, valued at
$193.3
Bought 24 shares
@ $6.17, valued at
$148.1
Bought 14 shares
@ $6.32, valued at
$88.5
Bought 27 shares
@ $6.37, valued at
$172
Bought 73 shares
@ $5.61, valued at
$409.5
Bought 42 shares
@ $6.29, valued at
$264.2
Bought 23 shares
@ $6.07, valued at
$139.6
Bought 58 shares
@ $6.35, valued at
$368.3
Bought 57 shares
@ $6.01, valued at
$342.6 |
|
| 04/12/2019 |
4
| Galante Joseph C (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 382 shares
@ $5.99, valued at
$2.3k
Bought 580 shares
@ $6.12, valued at
$3.5k
Bought 80 shares
@ $6, valued at
$480
Bought 241 shares
@ $6.19, valued at
$1.5k
Bought 183 shares
@ $6.32, valued at
$1.2k
Bought 60 shares
@ $6.41, valued at
$384.6 |
|
| 03/22/2019 |
4
| Galante Joseph C (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Granted 1,000 shares
@ $5.98, valued at
$6k
|
|
| 03/04/2019 |
4
| Galante Joseph C (Director) has filed a Form 4 on PINNACLE FINANCIAL PARTNERS INC|
Txns:
| Paid exercise price by delivering 253 shares
@ $58.93, valued at
$14.9k
Granted 1,273 shares
@ $0 |
|
| 09/28/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/02/2018 |
4
| Galante Joseph C (Director) has filed a Form 4 on PINNACLE FINANCIAL PARTNERS INC|
Txns:
| Granted 1,148 shares
@ $0 |
|
| 09/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|